Sera Prognostics, Inc. (SERA) - Latest Market Data

Price & Market Data

Price: $2.16

Daily Change: +$0.36 / 16.67%

Daily Range: $1.53 - $3.22

Market Cap: $81,058,560

Daily Volume: 539,094

Performance Metrics

1 Week: 3.43%

1 Month: -15.42%

3 Months: -30.38%

6 Months: -42.36%

1 Year: -4.74%

YTD: -39.06%

About Sera Prognostics, Inc. (SERA)

Explore the latest financial data for Sera Prognostics, Inc. (SERA). Price: 2.16, daily change: +$0.36 / 16.67%. Market cap: 81,058,560. Performance over 1-month, 6-month, and 1-year.

Company Details

Employees: 72

Sector: Health services

Industry: Medical/Nursing services

Country: United States

Details

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Selected stocks

Myseum.AI, Inc. (MYSE)

SemiLEDS Corporation (LEDS)

Dare Bioscience, Inc. (DARE)

Springview Holdings Ltd (SPHL)